Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate whether intracoronary bolus
administration of abciximab is superior to intravenous bolus administration in improving
myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing
primary percutaneous coronary intervention.
Phase:
N/A
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Abciximab Antibodies, Monoclonal Immunoglobulin Fab Fragments